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INTRODUCTION
Rap1 is a component of shelterin, the protein complex that functions to protect telomeres, recruits telomerase, and regulates telomere length (reviewed in Palm and de Lange, 2008) . Human shelterin contains two double-stranded (ds) telomeric DNA binding proteins, TRF1 and TRF2, which both interact with TIN2. TIN2 in turn binds heterodimers of TPP1 and the POT1 singlestranded (ss) telomeric DNA binding factor. Mammalian Rap1 relies on TRF2 to localize to telomeres (Li et al., 2000) . Similarly, the Rap1 orthologs of fission yeast and trypanosomes use a TRF1/2-like protein to accumulate at telomeres (Kanoh and Ishikawa, 2001; Yang et al., 2009) . In contrast, budding yeast Rap1 binds telomeric DNA directly (Konig et al., 1996) .
Rap1 was discovered as a Saccharomyces cerevisiae transcriptional regulator (repressor/activator protein) (Shore and Nasmyth, 1987) . All Rap1 proteins have an N-terminal BRCT motif, a C-terminal protein interaction domain, and one or two central Myb domains (Konig et al., 1996; Liu and Lustig, 1996; Hardy et al., 1992a; Wotton and Shore, 1997; Yang et al., 2009; Kanoh and Ishikawa, 2001; Li et al., 2000) . Budding yeast Rap1 binds to promoter and silencer elements and interacts with the silencing proteins Sir3p and Sir4p (Hardy et al., 1992a (Hardy et al., , 1992b Shore, 1994; Lickwar et al., 2012; Cockell et al., 1995) . Although mammalian Rap1 does not interact with sirtuins, it localizes to chromosome-internal sites and controls gene expression, affecting metabolism and body weight control (Yeung et al., 2013; Martínez et al., 2013; Yang et al., 2011) . Rap1 also regulates gene transcription in fission yeast and in the distantly related trypanosomes (Kanoh and Ishikawa, 2001; Yang et al., 2009) .
It is unclear which telomeric functions of Rap1 are conserved between yeast and mammals. Rap1 controls telomere length in yeast, acting to inhibit inappropriate telomere elongation (Lustig et al., 1990; Conrad et al., 1990; Sussel and Shore, 1991; Kyrion et al., 1992; Kanoh and Ishikawa, 2001 ). This control of telomere length is largely mediated by the Rap1-interacting factors Rif1 and Rif2 (Hardy et al., 1992a; Wotton and Shore, 1997; Levy and Blackburn, 2004; Teixeira et al., 2004) . In support of a role in telomere length control, small hairpin RNAs (shRNAs) to human Rap1 induce telomere lengthening (O'Connor et al., 2004) , as do overexpression of several Rap1 truncation mutants (Li and de Lange, 2003) . However, Rap1 knockout mice show no change in telomere length, even after three generations (Sfeir et al., 2010) . Additionally, mammalian Rif1 is not localized at telomeres (Silverman et al., 2004; Xu and Blackburn, 2004) , and there is no mammalian ortholog of Rif2.
It is also unclear whether the role of Rap1 in protection of telomeres from nonhomologous end-joining (NHEJ), which has been demonstrated in yeast (Pardo and Marcand, 2005; Miller et al., 2005) , is conserved in mammals. In vitro, human Rap1 can block NHEJ when it binds to TRF2 loaded on an end-joining substrate (Bae and Baumann, 2007) , and a Rap1-fusion protein can reduce telomere fusions when it is tethered to telomeres that are depleted of TRF2 (Sarthy et al., 2009 ). On the other hand, mouse cells lacking Rap1 show no telomere fusions and Rap1-deficient mice are alive and fertile (Sfeir et al., 2010; Martinez et al., 2010) . The only telomere deprotection phenotype in Rap1-deficient mouse cells is a propensity for telomere-telomere recombination when Ku70/80 are also absent (Sfeir et al., 2010) . To determine the function(s) of human Rap1, we used transcription activator-like effector nucleases (TALENs) to knock out the TERF2IP gene. Analysis of several independent Rap1-deficient cell lines demonstrated that human Rap1 was not required for telomere protection, telomere length regulation, and other aspects of telomere function. In contrast, we document a change in the transcription of several genes upon loss of Rap1, suggesting that its transcriptional function is primarily responsible for the high degree of Rap1 conservation from unicellular organisms to mammals.
RESULTS

Efficient TALEN-Mediated Knockout of Human Rap1
The human Rap1-encoding TERF2IP gene shares its promoter region with the essential KARS (lysyl-tRNA synthetase) gene located just upstream of exon 1 ( Figure 1A ). To avoid disrupting the KARS gene, we employed TALENs to delete exon 2, a targeting strategy analogous to the one used for mouse TERF2IP (Sfeir et al., 2010) (Figures 1A, S1A, and S1B). Deletion of exon 2 should result in an mRNA encoding a 226 aa open reading frame (ORF) that ends prematurely in a stop codon at the beginning of exon 3. As exon 3 encodes the TRF2-binding domain, the truncated Rap1 protein is not expected to localize to telomeres. Taking advantage of the small size of exon 2 (125 bp) and anticipated resection of TALENinduced double-strand breaks (DSBs) Urnov et al., 2010) , a neomycin donor construct was designed containing 5 0 and 3 0 arms homologous to the surrounding introns. Homology-directed repair (HDR) using the donor construct should result in deletion of exon 2 and insertion of the neomycin cassette.
TERF2IP was targeted in two near-diploid cancer lines (HCT116 colorectal carcinoma and HT1080 fibrosarcoma), a subclone of the near-triploid cervical carcinoma HeLa cell line (HeLa1.3; Takai et al., 2010) , the diploid ARPE-19 retinal pigment epithelial cell line, and primary BJ fibroblasts transformed with SV40 large T antigen (SV40LT). With the exception of SV40LT BJ, all cells expressed telomerase. For HCT116, HT1080, and ARPE-19 cells, neomycin resistant clones were obtained, analyzed by PCR, and then evaluated by Southern blotting to verify the correct neomycin insertion ( Figures 1B and 1C ). For HeLa1.3 and BJ, the blasticidin donor construct was used and clones were analyzed by immunoblotting for Rap1. This analysis identified clones that lacked the wild-type TERF2IP gene and expressed no detectable Rap1 protein ( Figures 1B, 1C , and S1C). We were unable to detect the polypeptides representing the remaining ORF of the targeted TERF2IP gene (Figures S1D-S1F), perhaps due to nonsense-mediated decay.
Unexpectedly, immunoblotting revealed the complete loss of Rap1 in heterozygous clones with one neo insertion ( Figures  1B and S1C ). Telomeric chromatin immunoprecipitation (ChIP) of two such clones (HT1080 c21 and HeLa1.3 c28) confirmed that Rap1 was absent from telomeres ( Figures 1D, 1E , S1G, and S1H). Sequencing revealed small deletions close to the TALEN site in these and other Rap1-deficient clones with only one neo-containing TERF2IP gene ( Figure S1B ). Most mutations had ablated Rap1 by deleting the exon 2 splice acceptor site or had created a frameshift mutation, indicating that errors generated during NHEJ had inactivated the TERF2IP gene ( Figure 1F ). As a result, the frequency of the TERF2IP knockouts (KOs) is much higher than deduced from PCR genotyping. Taking the deleterious repair events into account, the ablation of Rap1 occurred at 20%-65% efficiency in HCT116, HT1080, and ARPE-19 cells ( Figure 1G ). The HCT116 cells showed the highest KO frequency consistent with their propensity for HDR (reviewed in Sedivy et al., 1999) . The actual KO frequency is probably even higher, as only clones with a neo cassette in the TERF2IP gene were analyzed.
The high KO frequency allowed screening of HeLa1.3 and SV40LT BJ clones by Rap1 immunoblotting. Sequencing of Rap1-negative HeLa1.3 clones revealed that all three alleles in this cell line contained inactivating mutations near the TALEN cut site ( Figure S1B ). Prolonged culturing of clones in blasticidin resulted in cell death, suggesting that the EF-1 alpha promoter (pEF) blasticidin cassette did not confer long-term resistance. The KO frequency was lower in SV40LT BJ fibroblasts with only one blasticidin-resistant clone showing absence of Rap1 protein. This clone was not analyzed because it perished in telomere crisis, as did many of the Rap1-proficient SV40LT BJ clones.
Rap1-Deficient Cells Proliferate and Maintain Fully Protected Telomeres
The Rap1-deficient cell lines proliferated normally ( Figure 2A) and lacked a significant level of telomere dysfunction-induced foci (TIFs), a readout for telomere damage (Figures 2B and 2C) , indicating that removal of Rap1 from telomeres does not result in a DNA damage response.
Cells lacking Rap1 also did not show a significant induction of DSB repair at telomeres ( Figures 2D and 2E ). Metaphase spreads of Rap1 KOs lacked chromosome end fusions, a readout for telomeric NHEJ. Chromosome orientation (CO) fluorescence in situ hybridization (FISH) to monitor HDR-mediated telomere-sister chromatid exchanges (T-SCEs) established that recombination remained repressed at telomeres (Figures 2F and 2G) . Thus, human telomeres remain protected from NHEJ and HDR in the absence of Rap1.
Unaltered Telomere Length Dynamics in the Absence of Rap1
To determine whether Rap1 affected telomere length homeostasis, two HT1080 Rap1-deficient clones were cultured for 50 population doublings (PD) alongside two Rap1-proficient clones selected for their matching telomere lengths ( Figure 3A) . All clones exhibited a mild increase in telomere length ( Figure 3B ). The two Rap1-deficient clones lengthened their telomeres at a similar modest rate (1-2 bp/PD), whereas the two Rap1-proficient clones differed in the rate of telomere lengthening (28 and 4 bp/PD) (Figure 3B ). Given the clonal variation and small differences in telomere length changes, the removal of Rap1 did not appear to have a strong effect on telomere length dynamics in HT1080 cells.
Similarly, Rap1 did not affect the telomere length dynamics of HCT116 clones ( Figure 3C ). Two Rap1-deficient clones showed telomere shortening at variable rates (À3 to À32 bp/PD). Given that the telomere shortening in the parental cells (À27 bp/PD) is similar to that of one of the Rap1-deficient clones (c10), we conclude that also in HCT116 cells, Rap1 did not strongly affect telomere dynamics.
Finally, three Rap1-deficient ARPE-19 clones (c26, c25, and c30) showed wide variations in telomere dynamics, ranging from slight shortening (À18 bp/PD) to slight elongation (9 and 16 bp/PD) ( Figure 3D ). The single Rap1-proficient clone (c23) showed telomere shortening at a rate of À34 bp/PD. Thus, there is considerable variability in the telomere dynamics in ARPE-19 clones but no consistent effect of Rap1 deletion.
Given the lack of consistent shortening or lengthening phenotypes in multiple Rap1 KOs, the simplest interpretation is that Rap1 does not play a major role in telomere length regulation. Deletion of Rap1 also did not induce an obvious change in the telomere length heterogeneity ( Figures 3A and S2A ), which was affected by Rap1 mutants in overexpression studies (Li and de Lange, 2003) .
No Change in the Telomeric Overhang after Rap1 Loss
Removal of Rap1 from several cell lines also did not appear to affect the 3 0 telomeric overhang. The amount of ss telomeric DNA was determined by in-gel hybridization of a labeled C-strand telomeric repeat probe to native telomeric restriction fragments. Quantification of normalized ss telomeric DNA signals indicated that Rap1 status had no significant impact on the 3 0 overhangs in HT1080, HCT116, and ARPE-19 cells (Figures S2A and S2B) .
Unaltered Telomeric Positioning
To determine whether Rap1 is involved in the peripheral positioning of telomeres in newly formed G1 cells (Crabbe et al., 2012) , we used mitotic shake-off and analyzed daughter cells in early G1. Using lamin A to mark the nuclear envelope (NE) and FISH to visualize telomeres, the subnuclear position of the telomeric signals was determined and compared between Rap1-proficient and Rap1-deficient cells ( Figures 4A and 4B ). The distribution of telomeres in the nucleus and median distance from the nuclear envelope was similar for two Rap1-proficient and Rap1-deficient clones in two independent experiments. Moreover, the percentage of telomeres present in a zone defined arbitrarily as the nuclear periphery (within 10% distance from the NE) was also similar regardless of Rap1 status, illustrating that Rap1 is not required for the more peripheral positioning of telomeres in early G1.
Rap1 Affects Transcriptional Regulation, Not Telomeric Chromatin Modification
Mouse Rap1 localizes to over 8,600 gene-associated loci, affecting transcription of numerous genes (Martinez et al., 2010; Yeung et al., 2013; Martínez et al., 2013) , while human Rap1 is found at $63 gene loci (Yang et al., 2011) . To query the effect of Rap1 on the transcriptome, we performed microarray profiling on seven Rap1 wild-type (WT) and KO clones derived from three different cell lines: ARPE-19, HT1080, and HCT116. A number of differentially regulated genes were identified (Tables S1-S3 ). The three Rap1-regulated genes in the ARPE-19 cells (LHX2, LRRC17, and CDO1) were validated by quantitative RT-PCR (qRT-PCR), and their response to Rap1 deletion was further confirmed on an additional ARPE-19 Rap1 KO clone (c26) ( Figures S3A-S3C ). The Rap1-regulated genes varied between the different cell lines, most likely due to the different origins of the cell lines. Gene ontology analysis was uninformative, because of the low number of genes identified by this limited analysis. However, one Rap1-regulated gene in the HT1080 cells was among the human Rap1-associated loci in the HT1080-derived HTC75 cell line (Yang et al., 2011) . Taken together, these data are consistent with a role for Rap1 in transcriptional control in human cells. Despite the effects of Rap1 on gene expression there was no significant effect of Rap1 on the abundance of the telomeric long noncoding RNA called TERRA (telomeric repeat-containing RNA; reviewed in Feuerhahn et al., 2010) ( Figures  S3D and S3E ). This finding is consistent with the unaltered TERRA levels after deletion of mouse Rap1 (Sfeir et al., 2010) . Deletion of human Rap1 also had no detectable effect on general markers for the chromatin status at telomeres, as evidenced by ChIP for methylation of H3K9, acetylation of H4, and HP1a, HP1b, and HP1g ( Figures 4C and 4D ).
DISCUSSION
Based on the genetic data presented here, we conclude that human Rap1 is not required for the protection of telomeres from NHEJ and has no obvious effect on telomere length regulation, contrary to what was anticipated from other studies (Bae and Baumann, 2007; Sarthy et al., 2009; Li and de Lange, 2003; O'Connor et al., 2004) . In addition, telomeres lacking Rap1 remained protected from DNA damage signaling and HDR and had a normal 3 0 overhang. These findings are in agreement with the mouse Rap1 KO, which revealed no obvious phenotype other than that of telomeres becoming prone to undergo HDR when Ku70/80 was absent (Sfeir et al., 2010) . Whether human telomeres lacking Rap1 also recombine more readily in a Ku70/80-deficient setting is difficult to assess, since deletion of human Ku70/80 leads to rapid telomere loss and cell death (Li et al., 2002; Wang et al., 2009 ).
Despite this lack of requirement for Rap1 at telomeres, the human gene encoding Rap1 has diverged little from its chimpanzee counterpart (1 base change/100 codons; 0.25 aa changes/ 100 aa), whereas the genes for other shelterin components show much greater divergence (e.g., 3.6, 2.4, and 1.7 base changes/100 codons and 2.2, 1.1, and 0.65 aa changes/ 100 aa for TRF2, TRF1, and TIN2, respectively). Furthermore, assessment of a gene damage index for all protein-coding genes places TERF2IP in the top 20% of human genes with regard to mutation intolerance (Y. Itan, personal communication). In addition, Rap1 ranks among the top 10% of human genes in terms of ''functional indispensability,'' a characteristic that incorporates gene centrality (based on interaction data pooled from various biological systems), structural information, and evolutionary constraints (Khurana et al., 2013) . In this regard, only TIN2 scores higher than Rap1, as expected based on its multiple interaction interfaces in shelterin.
These results raise the question why Rap1 is conserved. It appears unlikely that protection of telomeres from HDR is its sole raison d'être, given the additional repression by Ku70/80. Furthermore, it seems unlikely that Rap1 has a tissue-specific role at telomeres, given that mice lacking Rap1 are alive and largely normal and the lack of telomeric phenotypes upon Rap1 deletion from four human cell lines of different tissue origin. The conservation of Rap1 is also not explained by a role in meiosis, since the Rap1 KO mice are fertile and, unlike yeast lacking Rap1, form a normal meiotic bouquet (Kanoh and Ishikawa, 2001; Chikashige and Hiraoka, 2001; Chikashige et al., 2006; Sfeir et al., 2010; Scherthan et al., 2011; Shibuya et al., 2014) . It is not excluded that Rap1, like TIN2, has (as yet unknown) multiple interactions within shelterin or interacts with shelterin-associated factors that explain its conservation or that its role at telomeres is redundant. However, we favor the idea that the conservation of Rap1 is due to its role in transcriptional regulation, where it may have multiple distinct interaction partners that constrain its evolution. It will be of interest to identify the Rap1-interacting partners that are at gene loci, since such partners may well be used by Rap1 to fulfill (as yet undefined) telomere functions.
Our data point to the difficulty in interpreting experiments in which telomeric phenotypes are observed upon overexpression of shelterin (mutant) proteins or their partial inactivation by shRNAs. We suspect that the prior finding of changes in telomere length and heterogeneity upon overexpression of Rap1 mutants (Li and de Lange, 2003) were due to nucleoplasmic titration of factors that (indirectly) influence these phenotypes. Similarly, the artificial tethering of Rap1 to telomeres may have had an effect on NHEJ that does not reflect the normal function of the protein (Sarthy et al., 2009) .
These data indicate that while mammalian Rap1 has functionally diverged away from its yeast predecessors, mouse and human Rap1 are very similar. Both Rap1 KO mice and human cells are viable, lack hallmarks of telomere dysfunction, and have no overt change in telomere length settings. While the Rap1 components of human and mouse shelterin are indistinguishable, it will be important to query the functions of other shelterin components and associated factors to gain a complete understanding of telomere maintenance and protection in human cells. Our data show that genetic approaches, such as the use of TALENs and CRISPR (Hsu et al., 2014) , are versatile tools to this effect.
EXPERIMENTAL PROCEDURES
Detailed experimental procedures are available in Supplemental Experimental Procedures. Cell culture techniques, telomere length analysis, telomeric overhang assay, analysis of metaphase spreads, TIF analysis, ChIP, telomeric FISH, immunofluorescence, and immunoblotting analysis were performed as described previously (Sfeir et al., 2010; Takai et al., 2010) . TALENs KO of TERF2IP was performed using standard protocols . The assay for telomeric position was published previously (Crabbe et al., 2012) . Microarray analysis was performed using Whole Human Genome DNA microarrays (Illumina HumanHT-12 v4) with GeneSpring v12.6 for data analysis.
ACCESSION NUMBERS
Microarray data have been deposited in the Gene Expression Omnibus under the accession number GSE61900. Yeung, F., Ramírez, C.M., Mateos-Gomez, P.A., Pinzaru, A., Ceccarini, G., Kabir, S., Ferná ndez-Hernando, C., and Sfeir, A. (2013 (H) Quantification of the percent of telomeric DNA recovered in each ChIP. Methods as in Figure 1D and E. (E) TERRA signals were normalized using the 18S ribosomal RNA and plotted as a ratio compared to the WT TERRA signal of the corresponding cell line. Error bars represent SDs.
SUPPLEMENTAL INFORMATION
Supplemental Information includes
Two-tailed unpaired t-tests of 3 independent experiments illustrates lack of statistical significance between Rap1 WT and KO TERRA expression levels. b CDCP1 was identified as a Rap1 associated locus by ChIP-seq in a subclone of HT1080 (Yang et al., 2011) . 
Supplemental Experimental Procedures TALENs and TERF2IP Targeting Construct
The heterodimeric TALEN pair for TERF2IP targeting was constructed using the following RVD 
TERF2IP Targeting and Cell cloning
All cell lines were transfected in 10 cm dishes at a density of 3x10 6 cells using Lipofectamine 2000 (Life Technologies) with 4 µg of each TALEN construct and 20 µg of the donor construct.
48 hours after transfection, all cell lines, except for HeLa1.3, were plated in selection medium in 10 cm plates at varying densities ranging from 3,900 to 500,000 cells (using two-fold dilutions). HeLa1.3 cells were plated in 10 cm dishes using two-fold dilutions starting from 8000 cells down to 75 cells. G418 was used at 1 mg/ml to select neomycin-resistant HCT116 cells, at 900 µg/ml for HT1080 cells, and at 800 µg/ml for ARPE-19 cells. Blasticidin was used at 5 µg/ml for HeLa1.3 selection and at 2.5 µg/ml for SV40LT BJ selection. Clones emerged at a Rap1 protein on western blots were sequenced by PCR amplifying the remaining 'WT' allele with primers F1 and R1 using the PCR conditions described above. The PCR products were eluted from agarose gels and sequenced with primers F1 and R1. The relevant TERF2IP PCR product from clones that lacked detectable Rap1 protein but appeared to be untargeted (homozygous 'WT') according to PCR genotyping and southern blotting were PCR amplified using primers F1 and R1, gel-eluted and cloned by TA cloning (Life Technologies). A minimum of 8 resulting TA clones per cell line were sequenced to identify mutations in both alleles. The latter procedure was applied to clones from the ARPE-19, SV40LT BJ, and HeLa1.3 cell lines.
Immunoblotting
Immunoblotting was performed as previously described (Takai et al., 2010) . Briefly, cells were harvested by trypsinization, resuspended in Laemmli buffer (100mM Tris-HCl pH 6.8, 200 mM DTT, 3% SDS, 20% glycerol, 0.05% bromophenol blue) at 10,000 cells per µl, denatured for 5 min at 95°C, sheared with an insulin needle, and resolved on SDS/PAGE gels using 100,000 cells per lane. Blots were blocked in 5% non-fat dry milk/PBS+0.1% Tween20. Antibodies used were as follows: Rap1 (765, rabbit polyclonal); alpha-tubulin (Sigma T9026). The hRap1 Ab was generated using full-length hRap1 recombinant protein as an antigen and reacts with multiple Rap1 domains.
Telomeric FISH and CO-FISH
Telomeric FISH and CO-FISH were conducted as previously described (van Steensel et al., 1998; Celli et al., 2006 Washing, mounting and capture conditions were as described for FISH.
Genomic Blotting, Telomere Overhang and Telomere Length Analysis
Cells were harvested by trypsinization, washed with PBS, and either pelleted and frozen at -80ºC (for telomere length analysis) or processed immediately (for genotyping and telomere overhang analysis) for genomic DNA collection. Genomic DNA was extracted as previously described (de Lange et al., 1990) . DNA for genotyping was digested with EcoRI, quantitated by fluorometry using Hoechst 33258 and 10 µg was loaded on a 0.7% agarose gel run in 0.5X TBE. DNA for telomere overhang and length analysis was digested with MboI and AluI, quantified using Hoechst, and 1 µg was run on 0.7% agarose gels in 0.5X TBE. For genomic blots used for genotyping and telomere length analysis, the gels were depurinated with 0.5N
HCl, denatured and neutralized using standard Southern blotting procedures and transferred as previously described (de Lange et al., 1990) . Blots were probed with a TERF2IP 5' arm probe (indicated in Fig. 1a , Klenow-labeled using random primers and α-32 P-dCTP) or a Sty11
probe (de Lange, 1992) for genotyping and telomere length analysis, respectively. For telomere overhang analysis, gels were dried and probed with a [CCCTAA]4 end-labeled with
Polynucleotide kinase and γ-32 P-ATP as previously described (Karlseder et al., 2002) . Gels and membranes were exposed to PhosphorImager screens and quantified with ImageQuant software.
Northern Analysis for TERRA
Total RNA was prepared using RNeasy Mini Spin columns (QIAGEN) according to the manufacturer's instructions and northern blot analysis was performed as previously described (Azzalin et al., 2007) . Briefly, 20µg of RNA was loaded onto 1.2% formaldehyde agarose gels and separated by gel electrophoresis. RNA was transferred to a Hybond-N+ membrane and crosslinked in a UV Stratalinker. The blot was prehybridized in Church mix at 55°C for 1 hour, followed by overnight hybridization with a Sty11 probe (de Lange, 1992) . The blot was washed 3 times for 15 minutes at 55°C with Church wash and then exposed to a Phosphorimager screen for 5 days. Screens were scanned using ImageQuant software and quantified in Image J using the ethidium bromide stained 18S RNA as a loading control for normalization.
Total RNA was isolated from cell lines using RNeasy Mini spin columns (QIAGEN) with DNase digestion, according to the manufacturer's instructions. Microarray hybridization and scanning were performed at the Genomics core facility at Rockefeller University, using Whole Human Genome DNA microarrays (Illumina HumanHT-12 v4). The data was analyzed using GeneSpring v12.6. Normalization was performed using quantiles and data was filtered to remove absent genes using flag calls. Experiments for HT1080 and HCT116 cell lines were performed in replicate, using two independent isolations of RNA. Differentially expressed genes were identified after performing moderated T-Tests and applying the Benjamini-Hochberg False Discovery Rate method. A further fold change of 3 or 2.75 was applied to the HT1080 and HCT116 clones respectively to identify genes that were highly transcriptionally deregulated due to the absence of Rap1. Microarrays for ARPE-19 were not performed in replicate and therefore an extremely stringent fold change threshold was applied to remove false negatives and identify differentially expressed genes, which were subsequently validated by qRT-PCR.
For qRT-PCR, cDNA was prepared from 1µg of total RNA by using Thermoscript Reverse Transcriptase (Invitrogen). Quantitative PCR reactions were performed using Life Technologies SYBR Green Master Mix on an Applied Biosystems 7900HT Sequence Detection System. Differences between samples calculated using QuantStudio software (Applied Biosystems) using the ΔCT method and were normalized to GAPDH. Two independent isolations of RNA and reverse transcriptase reactions were conducted and the experiment was repeated six times for clones 23, 25, 30 and the parental cell line. The experiment for clone 26 was conducted in triplicate. Data was pooled to derive the mean averages and standard deviations.
Significance was calculated using a two-tailed unpaired T-Test.
